Jun 02, 2025 22:30
EPRX - Eupraxia Pharmaceuticals Inc. Common Stock
Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
---|---|---|---|---|---|---|---|
5.98 -0.05 (-0.84%) | --- | --- | --- | --- | -0.05 (-0.84%) | --- | --- |
Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages its proprietary Diffusphere technology to optimize drug delivery for applications with unmet medical needs.
Category:
/stock/categories/na
Market Period:
AfterHours
Earnings & Ratios
- Basic EPS:
- Diluted EPS:
- Basic P/E:
- Diluted P/E:
- RSI(14) 1m:
- 45.45
- VWAP:
- 5.94
- RVol:
- 0.1509
Events
Period | Kind | Movement | Occurred At |
---|
Related News
May 15, 2025 21:00
May 07, 2025 18:00
May 06, 2025 22:00
Apr 24, 2025 21:00
Apr 08, 2024 09:15